(Q82641280)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19016350%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Response to neo-adjuvant chemotherapy in BRCA1 and BRCA2 related stage III breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19016350%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Ayala Hubert

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19016350%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Bela Mali

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19016350%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Tamar Hamburger

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19016350%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Yakir Rottenberg

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19016350%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Beatrice Uziely

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19016350%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Tamar Peretz

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19016350%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Luna Kadouri

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19016350%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

19 November 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19016350%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19016350%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19016350%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19016350%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

173-177

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19016350%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10689-008-9223-7

17 January 2020

exact match

0 references

cites work

Survival and tumor characteristics of German hereditary breast cancer patients

1 reference

12 December 2020

Familial invasive breast cancers: worse outcome related to BRCA1 mutations

1 reference

12 December 2020

BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention

1 reference

12 December 2020

Cell proliferation and apoptosis in BRCA-associated hereditary ovarian cancer

1 reference

12 December 2020

Effect of BRCA Mutations on the Length of Survival in Epithelial Ovarian Tumors

1 reference

12 December 2020

Clinicopathologic features of BRCA-linked and sporadic ovarian cancer

1 reference

12 December 2020

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

1 reference

12 December 2020

The p53 mutational spectrum associated with BRCA1 mutant ovarian cancer.

1 reference

12 December 2020

Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations

1 reference

12 December 2020

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

1 reference

12 December 2020

Survival in epithelial ovarian cancer patients with prior breast cancer

1 reference

12 December 2020

A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer

1 reference

12 December 2020

Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma

1 reference

12 December 2020

BRCA1 and BRCA2: chemosensitivity, treatment outcomes and prognosis

1 reference

12 December 2020

TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution.

1 reference

12 December 2020

Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair.

1 reference

12 December 2020

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations

1 reference

12 December 2020

Bilaterales Mammakarzinom und Lokalrezidiv: Prävalenz von BRCA-1- und BRCA-2-Genmutationen an einem unselektionierten Kollektiv

1 reference

12 December 2020

Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer.

1 reference

12 December 2020

BRCA1 directs a selective p53-dependent transcriptional response towards growth arrest and DNA repair targets

1 reference

12 December 2020

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

1 reference

12 December 2020

Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage

1 reference

12 December 2020

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment

1 reference

12 December 2020